Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nyse:mrk

POPULAR ARTICLES

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir in Adults with Virologically Suppressed HIV-1 Infection

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir in Adults with Virologically Suppressed HIV-1 Infection

Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025

Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025

Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025

Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025

LATEST ARTICLES

Merck Completes Acquisition of Verona Pharma

Merck Completes Acquisition of Verona Pharma

Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30

Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30

WINREVAIR Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial

WINREVAIR Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial

FDA Approves Merck's KEYTRUDA QLEX Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA®

FDA Approves Merck's KEYTRUDA QLEX Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA®

Merck Receives Positive EU CHMP Opinion for ENFLONSIA for the Prevention of Respiratory Syncytial Virus in Infants During Their First RSV Season

Merck Receives Positive EU CHMP Opinion for ENFLONSIA for the Prevention of Respiratory Syncytial Virus in Infants During Their First RSV Season

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® , for Subcutaneous Administration and for New Indication for Earlier-Stage Head and Neck Cancer

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® , for Subcutaneous Administration and for New Indication for Earlier-Stage Head and Neck Cancer

Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab

Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab

CAPVAXIVE® Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease

CAPVAXIVE® Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease

Merck Announces First-Quarter 2023 Financial Results

life science investing

Merck Announces First-Quarter 2023 Financial Results

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. , BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc.

life science investing

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. , BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc.

Pharma Market Update: H1 2021 in Review

pharmaceutical investing

Pharma Market Update: H1 2021 in Review

pharmaceutical investing

Merck Announces Q4 and Full-Year 2019 Financial Results

Latest News

AFDG via Butembo Acquisition Becomes First US Public Company in the Democratic Republic of the Congo (DRC)

Troy Minerals Updates on Channel Sampling at Table Mountain High-Purity Silica Project, British Columbia, Canada

CoTec Commissions BBA to Lead Feasibility Study for the Lac Jeannine Iron Tailings Recovery Project

Standard Uranium Confirms Strong Radioactivity at Surface During Successful Exploration Program at the Rocas Uranium Project

Spartan Metals Commences Exploration Program at the Eagle Tungsten-Silver-Rubidium Project, Nevada

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Agriculture

Base Metals
Critical Metals
- Rare Earths
Energy
- Uranium
- Oil and Gas

- Crypto
- Cleantech

- Biotech
- Cannabis

- Pharmaceuticals

Featured Stocks

JZR Gold

JZR:CA

Prismo Metals

PRIZ:CNX

CoTec Holdings

CTH:CA

Empire Metals

EPMLF

RemSense Technologies

REM:AU

Metro Mining

MMI:AU

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES